After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The variant, first detected in the U.S. in late March, has now been identified in arriving international travelers through ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The US Centers for Disease Control and Prevention lists a wide range of conditions that may make someone more likely to become severely ill with Covid-19, including older age, asthma, diabetes ...

The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...

At the outset of the meeting, the FDA's new top vaccine regulator, Vinay Prasad, said he and FDA leaders wanted to "give people a little more time to digest the policy." He said that the FDA is still ...